- Page 1 and 2:
An Introduction to Medicinal Chemis
- Page 3 and 4:
Preface This text is aimed at under
- Page 5 and 6:
Contents Classification of drugs xi
- Page 7 and 8:
Contents
- Page 9 and 10:
Contents xi 11.16.2 Structure
- Page 11 and 12:
Classification of drugs
- Page 13 and 14:
1 • Drugs and the medicinal chemi
- Page 15 and 16:
Whilst penicillin Drugs and the med
- Page 17:
Drugs
- Page 22 and 23:
10 The why and the wherefore Cytopl
- Page 25:
Where do drugs work? 13 Amphoterici
- Page 28:
16 Protein structure [ H O
- Page 31 and 32:
The tertiary structure of proteins
- Page 33 and 34:
The tertiary structure of proteins
- Page 36 and 37:
24 Protein structure H-Bond Peptide
- Page 38:
26 Protein structure again that ter
- Page 43 and 44:
Substrate binding
- Page 45 and 46:
Substrate binding at an active site
- Page 47:
Substrate binding
- Page 53 and 54:
R The catalytic role of enzymes Thy
- Page 55 and 56:
I NH 2 CHO (OH Condensation R< The
- Page 59 and 60: Nerve Neurotransmitters
- Page 61 and 62: Receptors
- Page 64 and 65: 52 Drug action at receptors Induced
- Page 66 and 67: 54 Drug action at receptors MESSENG
- Page 68: 56 Drug action at receptors RECEPTO
- Page 72 and 73: 60 Drug action at receptors left-ha
- Page 74 and 75: 62 Drug action
- Page 76 and 77: 64 Drug action
- Page 78 and 79: 66 Drug action at receptors D Neuro
- Page 81 and 82: Structure of DNA 69 NH 2 NHo NHo Ad
- Page 83 and 84: Structure
- Page 85 and 86: Drugs acting
- Page 87: Drugs acting on DNA 75 CH3—N: MEC
- Page 90 and 91: 78 Nucleic acids end AMINO «A/* Ba
- Page 93: Summary 81
- Page 96 and 97: 84 Drug development
- Page 98 and 99: 86 Drug development | | Potential I
- Page 100 and 101: 88 Drug development bonding or not,
- Page 102 and 103: 90 Drug development 7.5.1 Variation
- Page 104 and 105: 92 Drug development covered
- Page 106 and 107: 94 Drug development avoiding patent
- Page 108 and 109: 96 Drug development ,OH OH GLIPINE
- Page 114 and 115: 102 Drug development Frequently,
- Page 116 and 117: 104 Drug development O IIS—NH —
- Page 118 and 119: Et 2NCH 2CH 2 CH 2NEt 2
- Page 120 and 121: 108 Drug development Zero Activity
- Page 122: 110 Drug development found
- Page 125: Drug distribution and 'survival' 11
- Page 128 and 129: 116 Pharmacodynamics Drugs
- Page 130 and 131: 118 Pharmacodynamics Other common m
- Page 132 and 133: 120 Pharmacodynamics
- Page 134 and 135: 122 Pharmacodynamics Me AZATHIOPRIN
- Page 136 and 137: 124 Pharmacodynamics Many peptides
- Page 138 and 139: 126 Pharmacodynamics 8.3.9 Self-des
- Page 141 and 142: Graphs and equations 129 What are t
- Page 143 and 144: Physicochemical properties
- Page 145 and 146: Physicochemical properties
- Page 147 and 148: Physicochemical properties
- Page 149 and 150: Physicochemical properties
- Page 151 and 152: Meta Hydroxyl Group Physicochemical
- Page 153 and 154: Quantifying steric properties Hansc
- Page 155 and 156: log [I] The Craig plot 143
- Page 157 and 158: The Topliss scheme 145 and electron
- Page 159 and 160: The Topliss scheme 147 with a negat
- Page 161 and 162:
Planning
- Page 163 and 164:
Case study
- Page 168:
156 Antibacterial agents prontosil
- Page 171:
Antibacterial agents which
- Page 174 and 175:
162 Antibacterial agents MeO OMe Fi
- Page 176 and 177:
164 Antibacterial agents Fig. 10.15
- Page 178 and 179:
166 Antibacterial agents drug would
- Page 180 and 181:
168 Antibacterial agents -CH2- R—
- Page 182 and 183:
170 Antibacterial agents • Ineffe
- Page 185 and 186:
Antibacterial agents which inhibit
- Page 187 and 188:
Antibacterial agents which inhibit
- Page 189 and 190:
Antibacterial agents which inhibit
- Page 191 and 192:
groups Antibacterial agents which i
- Page 193:
Antibacterial agents which inhibit
- Page 196 and 197:
184 Antibacterial agents Fig. 10.45
- Page 198 and 199:
186 Antibacterial agents = CH 3 C0
- Page 200 and 201:
188 Antibacterial agents Second- an
- Page 202 and 203:
190 Antibacterial agents Fig. 10.54
- Page 204 and 205:
192 Antibacterial agents
- Page 206 and 207:
194 Antibacterial agents [Normal Me
- Page 208 and 209:
196 Antibacterial agents L-Valine M
- Page 210 and 211:
198 Antibacterial agents L-LEU —
- Page 212 and 213:
200 Antibacterial agents which was
- Page 214 and 215:
202 Antibacterial agents o ,CO2H HN
- Page 216 and 217:
204 Antibacterial agents transferre
- Page 218 and 219:
206 The peripheral nervous system y
- Page 220 and 221:
208 The peripheral nervous system S
- Page 222 and 223:
210 The peripheral nervous system N
- Page 224 and 225:
212 The peripheral nervous system 1
- Page 227:
Agonists at the cholinergic recepto
- Page 231 and 232:
Water Design of acetylcholine analo
- Page 233:
Design
- Page 236 and 237:
224 The peripheral nervous system H
- Page 239 and 240:
A large variety Antagonists of the
- Page 241 and 242:
Antagonists
- Page 243 and 244:
Antagonists
- Page 245:
drug design Other cholinergic antag
- Page 249 and 250:
Anticholinesterases
- Page 251:
Anticholinesterase drugs 239 - Pyrr
- Page 254 and 255:
242 The peripheral nervous system M
- Page 256 and 257:
244 The peripheral nervous system F
- Page 259 and 260:
N—CH 3 MeO. R'O* R
- Page 261:
Morphine 249 12.2 Morphine 12.2.1 S
- Page 265:
Morphine 253 To conclude, the 6-hyd
- Page 269 and 270:
Development
- Page 271 and 272:
Development of morphine analogues 2
- Page 273 and 274:
Development
- Page 275 and 276:
Development
- Page 277 and 278:
Development of morphine analogues 2
- Page 279:
Development of morphine analogues 2
- Page 282 and 283:
270 The opium analgesics analgesic
- Page 284 and 285:
272 The opium analgesics acts as a
- Page 287:
Enkephalins
- Page 290 and 291:
278 The opium analgesics narcotic a
- Page 292:
280 The opium analgesics O II N —
- Page 297:
Searching
- Page 301 and 302:
Searching for a lead—AT-guanylhis
- Page 303:
Developing the lead—a chelation b
- Page 307:
Development of metiamide 295 meanin
- Page 311:
Development
- Page 315 and 316:
Further studies—cimetidine analog
- Page 317 and 318:
Further studies—cimetidine analog
- Page 319 and 320:
Further studies—cimetidine analog
- Page 321:
Famotidine and nizatidine 309 • R
- Page 325 and 326:
Appendix
- Page 327:
(vesicles) containing The action of
- Page 331 and 332:
The action of nerves 319 x Briv "-
- Page 333 and 334:
Secondary messengers
- Page 335:
Secondary messengers 323 the proces
- Page 338 and 339:
Appendix 4 • Bacteria and bacteri
- Page 340 and 341:
Glossary ADDICTION Addiction can be
- Page 342 and 343:
Further reading Albert,
- Page 345 and 346:
drug addiction 1, 3, 5, 127, 248, 2
- Page 347 and 348:
penillic acids 172 pentagastrin Ind